Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

2005 
Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    28
    References
    147
    Citations
    NaN
    KQI
    []